Skip to main content

Table 1 Description of neuropsychological and clinical efficacy outcome measures

From: Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)

Abbreviation

Full Name

Description

Reference

Neuropsychological Measures

   

 HVLT-R

Hopkins Verbal Learning Test – Revised

Anterograde verbal learning and memory assessment

[47]

 AMI-SF

Autobiographical Memory Inventory – Short Form

Retrograde assessment of personal memories

[59]

 COWAT – letter and category

Controlled Oral Word Association Test

Letter and Category fluency assessment

[60]

 MCG – Complex Figure Test

Medical College of Georgia Complex Figure Test

Anterograde visuospatial memory assessment

[61]

 Digit Span

Digit Span

Working memory assessment

[62]

 GSE-My

Global Self-Evaluation of Memory

Self-reported assessment of memory

[63]

 Reorientation

Reorientation

Number of 5 orientation items correct 30 and 60 min after ECT

[64]

Clinical Efficacy Measures

   

 MADRS

Montgomery-Ã…sberg Depression Rating Scale

Observer-rated assessment of depressive symptoms

[48]

 CAS

Clinical Anxiety Scale

Observer-rated assessment of anxiety symptoms

[65]

 BPRS

Brief Psychiatric Rating Scale

Observer-rated assessment of psychiatric symptoms

[66]

 CGI-S, CGI-I

Clinical Global Impression – Severity and Improvement

Observer-rated global measure of illness severity and improvement

[67]

 QIDS-SR

Quick Inventory Depressive Symptomology – Self Rated

Self-rated measure of depressive symptoms

[68]

 EQ-5D

EuroQol

Self-rated measure of health-related quality of life

[69]